Mood and gut feelings

Brain, Behavior, and Immunity

Volumn 24, Issue 1, 2010, Pages 9-16

  Forsythe, Paul ^a,b   Sudo, Nobuyuki ^c   Dinan, Timothy ^d   Taylor, Valerie H ^b   Bienenstock, John ^a,b  

^a Brain Body Institute   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c KYUSHU UNIVERSITY   (Japan)

^d UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Behavior; Commensal bacteria; Mood disorders; Nervous system

Indexed keywords

BRAIN; COMMENSAL; COMORBIDITY; ENTERITIS; HEALTH STATUS; HOST; HUMAN; INTESTINE FLORA; INTESTINE INNERVATION; MENTAL DISEASE; MOOD; MOOD DISORDER; NERVOUS SYSTEM DEVELOPMENT; NERVOUS SYSTEM FUNCTION; NONHUMAN; OBESITY; PHYSICAL DISEASE; PRIORITY JOURNAL; REVIEW; SYMBIOSIS;

AFFECT; ANIMALS; BACTERIA; CELL WALL; CYTOKINES; FATTY ACIDS, VOLATILE; GASTROINTESTINAL TRACT; HUMANS; NERVOUS SYSTEM PHYSIOLOGICAL PHENOMENA; NEUROTRANSMITTER AGENTS; SIGNAL TRANSDUCTION;

EID: 71749090997     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2009.05.058     Document Type: Review

References (96)

1. Alesci S., Martinez P.E., Kelkar S., Ilias I., Ronsaville D.S., Listwak S.J., Ayala A.R., Licinio J., Gold H.K., Kling M.A., Chrousos G.P., and Gold P.W. Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications. J. Clin. Endocrinol. Metab. 90 (2005) 2522-2530
2. Amaral F.A., Sachs D., Costa V.V., Fagundes C.T., Cisalpino D., Cunha T.M., Ferreira S.H., Cunha F.Q., Silva T.A., Nicoli J.R., Vieira L.Q., Souza D.G., and Teixeira M.M. Commensal microbiota is fundamental for the development of inflammatory pain. Proc. Natl. Acad. Sci. USA 105 (2008) 2193-2197
3. Anisman H., and Merali Z. Cytokines, stress and depressive illness: brain-immune interactions. Ann. Med. 35 (2003) 2-11
4. Backhed F., Ding H., Wang T., Hooper L.V., Koh G.Y., Nagy A., Semenkovich C.F., and Gordon J.I. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. USA 101 (2004) 15718-15723
5. Banks W.A. The blood-brain barrier in psychoneuroimmunology. Immunol. Allergy Clin. North Am. 29 (2009) 223-228
6. Belmaker R.H., and Agam G. Major depressive disorder. N. Engl. J. Med. 358 (2008) 55-68
7. Bomba A., Nemcova R., Gancarcikova S., Herich R., Guba P., and Mudronova D. Improvement of the probiotic effect of micro-organisms by their combination with maltodextrins, fructo-oligosaccharides and polyunsaturated fatty acids. Br. J. Nutr. 88 Suppl. 1 (2002) S95-S99
8. Boveri M., Kinsner A., Berezowski V., Lenfant A.M., Draing C., Cecchelli R., Dehouck M.P., Hartung T., Prieto P., and Bal-Price A. Highly purified lipoteichoic acid from gram-positive bacteria induces in vitro blood-brain barrier disruption through glia activation: role of pro-inflammatory cytokines and nitric oxide. Neuroscience 137 (2006) 1193-1209
9. Burke H.M., Davis M.C., Otte C., and Mohr D.C. Depression and cortisol responses to psychological stress: a meta-analysis. Psychoneuroendocrinology 30 (2005) 846-856
10. Capuron L., Raison C.L., Musselman D.L., Lawson D.H., Nemeroff C.B., and Miller A.H. Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy. Am. J. Psychiatry 160 (2003) 1342-1345
11. Carroll B.J., Cassidy F., Naftolowitz D., Tatham N.E., Wilson W.H., Iranmanesh A., Liu P.Y., and Veldhuis J.D. Pathophysiology of hypercortisolism in depression. Acta Psychiatr. Scand. Suppl. 90 (2007) 103
12. Chengappa K.N.R., Kupfer D.J., Parepally H., John V., Basu R., Buttenfield J., Schlict P., Houck P., Brar J.S., and Gershon S. The prevalence of the metabolic syndrome in patients with schizoaffective disorder-bipolar subtype. Bipolar Disord. 6 (2004) 314-318
13. Clarke M.B., Hughes D.T., Zhu C., Boedeker E.C., and Sperandio V. The QseC sensor kinase: a bacterial adrenergic receptor. Proc. Natl. Acad. Sci. USA 103 (2006) 10420-10425
14. Collins S.M., and Bercik P. The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology 136 (2009) 2003-2014
15. Cooper R.S. Gene-environment interactions and the etiology of common complex disease. Ann. Intern. Med. 139 (2003) 437-440
16. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., and Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 9 (2008) 46-56
17. Desbonnet L., Garrett L., Clarke G., Bienenstock J., and Dinan T.G. The probiotic Bifidobacteria infantis: an assessment of potential antidepressant properties in the rat. J Psychiatr Res. 43 (2008) 164-174
18. Duncker S.C., Wang L., Hols P., and Bienenstock J. The d-alanine content of lipoteichoic acid is crucial for Lactobacillus plantarum-mediated protection from visceral pain perception in a rat colorectal distension model. Neurogastroenterol. Motil. 20 (2008) 843-850
19. Fagiolini A., Kupfer D.J., Houck P.R., Novick D.M., and Frank E. Obesity as a correlate of outcome in patients with bipolar I disorder. Am. J. Psychiatry 160 (2003) 112-117
20. Fallon B.A., and Nields J.A. Lyme disease: a neuropsychiatric illness. Am. J. Psychiatry 151 (1994) 1571-1583
21. Forsythe P., Inman M.D., and Bienenstock J. Oral treatment with live Lactobacillus reuteri inhibits the allergic airway response in mice. Am. J. Respir. Crit. Care Med. 175 (2007) 561-569
22. Frank D.N., and Pace N.R. Gastrointestinal microbiology enters the metagenomics era. Curr. Opin. Gastroenterol. 24 (2008) 4-10
23. Freeman M.P., Hibbeln J.R., Wisner K.L., Davis J.M., Mischoulon D., Peet M., Keck Jr. P.E., Marangell L.B., Richardson A.J., Lake J., and Stoll A.L. Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J. Clin. Psychiatry 67 (2006) 1954-1967
24. Freestone P.P., Sandrini S.M., Haigh R.D., and Lyte M. Microbial endocrinology: how stress influences susceptibility to infection. Trends Microbiol. 16 (2008) 55-64
25. Gaykema R.P., Goehler L.E., and Lyte M. Brain response to cecal infection with Campylobacter jejuni: analysis with Fos immunohistochemistry. Brain Behav. Immun. 18 (2004) 238-245
26. Gilad G.M., and Gilad V.H. Overview of the brain polyamine-stress-response: regulation, development, and modulation by lithium and role in cell survival. Cell. Mol. Neurobiol. 23 (2003) 637-649
27. Gilad G.M., Gilad V.H., Casanova M.F., and Casero Jr. R.A. Polyamines and their metabolizing enzymes in human frontal cortex and hippocampus: preliminary measurements in affective disorders. Biol. Psychiatry 38 (1995) 227-234
28. Goehler L.E., Gaykema R.P., Opitz N., Reddaway R., Badr N., and Lyte M. Activation in vagal afferents and central autonomic pathways: early responses to intestinal infection with Campylobacter jejuni. Brain Behav. Immun. 19 (2005) 334-344
29. Goehler L.E., Park S.M., Opitz N., Lyte M., and Gaykema R.P. Campylobacter jejuni infection increases anxiety-like behavior in the holeboard: possible anatomical substrates for viscerosensory modulation of exploratory behavior. Brain Behav. Immun. 22 (2008) 354-366
30. Grangette C., Nutten S., Palumbo E., Morath S., Hermann C., Dewulf J., Pot B., Hartung T., Hols P., and Mercenier A. Enhanced antiinflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids. Proc. Natl. Acad. Sci. USA 102 (2005) 10321-10326
31. Guthrie G.D., and Nicholson-Guthrie C.S. Gamma-Aminobutyric acid uptake by a bacterial system with neurotransmitter binding characteristics. Proc. Natl. Acad. Sci. USA 86 (1989) 7378-7381
32. Hansen M.K., O'Connor K.A., Goehler L.E., Watkins L.R., and Maier S.F. The contribution of the vagus nerve in interleukin-1beta-induced fever is dependent on dose. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280 (2001) R929-R934
33. Hart B.L. Biological basis of the behavior of sick animals. Neurosci. Biobehav. Rev. 12 (1988) 123-137
34. Hauser P., Khosla J., Aurora H., Laurin J., Kling M.A., Hill J., Gulati M., Thornton A.J., Schultz R.L., Valentine A.D., Meyers C.A., and Howell C.D. A prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis C. Mol. Psychiatry 7 (2002) 942-947
35. Heiskanen T.H., Niskanen L.K., Hintikka J.J., Koivumaa-Honkanen H.T., Honkalampi K.M., Haatainen K.M., and Viinamaki H. Metabolic syndrome and depression: a cross-sectional analysis. J. Clin. Psychiatry 67 (2006) 1422-1427
36. Higuchi T., Hayashi H., and Abe K. Exchange of glutamate and gamma-aminobutyrate in a Lactobacillus strain. J. Bacteriol. 179 (1997) 3362-3364
37. Holsboer F. Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy. J. Affect. Disord. 62 (2001) 77-91
38. Horrobin D.F. Food, micronutrients, and psychiatry. Int. Psychogeriatr. 14 (2002) 331-334
39. Hoverstad T., and Midtvedt T. Short-chain fatty acids in germfree mice and rats. J. Nutr. 116 (1986) 1772-1776
40. Hughes D.T., and Sperandio V. Inter-kingdom signalling: communication between bacteria and their hosts. Nat. Rev. Microbiol. 6 (2008) 111-120
41. Iyer L.M., Aravind L., Coon S.L., Klein D.C., and Koonin E.V. Evolution of cell-cell signaling in animals: did late horizontal gene transfer from bacteria have a role?. Trends Genet. 20 (2004) 292-299
42. Kamiya T., Wang L., Forsythe P., Goettsche G., Mao Y., Wang Y., Tougas G., and Bienenstock J. Inhibitory effects of Lactobacillus reuteri on visceral pain induced by colorectal distension in Sprague-Dawley rats. Gut 55 (2006) 191-196
43. Kamm K., Hoppe S., Breves G., Schroder B., and Schemann M. Effects of the probiotic yeast Saccharomyces boulardii on the neurochemistry of myenteric neurones in pig jejunum. Neurogastroenterol. Motil. 16 (2004) 53-60
44. Kankaanpaa P.E., Yang B., Kallio H.P., Isolauri E., and Salminen S.J. Influence of probiotic supplemented infant formula on composition of plasma lipids in atopic infants. J. Nutr. Biochem. 13 (2002) 364-369
45. Karimi K., Inman M.D., Bienenstock J., and Forsythe P. Lactobacillus reuteri induced regulatory t cells protect against an allergic airway response in mice. Am J Respir Crit Care Med. 179 (2008) 186-193
46. Kinross J.M., von Roon A.C., Holmes E., Darzi A., and Nicholson J.K. The human gut microbiome: implications for future health care. Curr. Gastroenterol. Rep. 10 (2008) 396-403
47. Kuda T., Enomoto T., Yano T., and Fujii T. Cecal environment and TBARS level in mice fed corn oil, beef tallow and menhaden fish oil. J. Nutr. Sci. Vitaminol. (Tokyo) 46 (2000) 65-70
48. Kunze, W., Mao, Y.K., Wang, B., Huizinga, J.D., Ma, X., Forsythe, P., Bienenstock, J., 2009. Lactobacillus reuteri enhances excitability of colonic AH neurons by inhibiting calcium dependent potassium channel opening. J. Cell. Mol. Med., in press [Epub ahead of print].
49. Kurokawa K., Itoh T., Kuwahara T., Oshima K., Toh H., Toyoda A., Takami H., Morita H., Sharma V.K., Srivastava T.P., Taylor T.D., Noguchi H., Mori H., Ogura Y., Ehrlich D.S., Itoh K., Takagi T., Sakaki Y., Hayashi T., and Hattori M. Comparative metagenomics revealed commonly enriched gene sets in human gut microbiomes. DNA Res. 14 (2007) 169-181
50. Li W., Dowd S.E., Scurlock B., Acosta-Martinez V., and Lyte M. Memory and learning behavior in mice is temporally associated with diet-induced alterations in gut bacteria. Physiol. Behav. 96 (2009) 557-567
51. Lesperance F., Frasure-Smith N., Talajic M., and Bourassa M.G. Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation 105 (2002) 1049-1053
52. Lyte M., Li W., Opitz N., Gaykema R.P., and Goehler L.E. Induction of anxiety-like behavior in mice during the initial stages of infection with the agent of murine colonic hyperplasia Citrobacter rodentium. Physiol. Behav. 89 (2006) 350-357
53. MacFabe D.F., Cain D.P., Rodriguez-Capote K., Franklin A.E., Hoffman J.E., Boon F., Taylor A.R., Kavaliers M., and Ossenkopp K.P. Neurobiological effects of intraventricular propionic acid in rats: possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders. Behav. Brain Res. 176 (2007) 149-169
54. Macpherson A.J., and Uhr T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 303 (2004) 1662-1665
55. Maes M. The immunoregulatory effects of antidepressants. Hum. Psychopharmacol. 16 (2001) 95-103
56. Mazmanian S.K., Round J.L., and Kasper D.L. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453 (2008) 620-625
57. McElroy S.L., Frye M.A., Suppes T., Dhavale D., Keck Jr. P.E., Leverich G.S., Altshuler L., Denicoff K.D., Nolen W.A., Kupka R., Grunze H., Walden J., and Post R.M. Correlates of overweight and obesity in 644 patients with bipolar disorder. J. Clin. Psychiatry 63 (2002) 207-213
58. Merali Z., Du L., Hrdina P., Palkovits M., Faludi G., Poulter M.O., and Anisman H. Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABA(A) receptor subunits in frontal cortical brain region. J. Neurosci. 24 (2004) 1478-1485
59. Mill J., and Petronis A. Molecular studies of major depressive disorder: the epigenetic perspective. Mol. Psychiatry 12 (2007) 799-814
60. Moussavi S., Chatterji S., Verdes E., Tandon A., Patel V., and Ustun B. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 370 (2007) 851-858
61. Musselman D.L., Lawson D.H., Gumnick J.F., Manatunga A.K., Penna S., Goodkin R.S., Greiner K., Nemeroff C.B., and Miller A.H. Paroxetine for the prevention of depression induced by high-dose interferon alfa. N. Engl. J. Med. 344 (2001) 961-966
62. Nakajima K., Tooyama I., Kuriyama K., and Kimura H. Immunohistochemical demonstration of GABAB receptors in the rat gastrointestinal tract. Neurochem. Res. 21 (1996) 211-215
63. Neufeld K.M., Bienenstock J., and Foster J.A. The impact of intestinal microbiota on anxiety-like behaviour. Neurogastroenterol. Motil. 20 Suppl. 2 (2008) 125
64. O'Mahony L., McCarthy J., Kelly P., Hurley G., Luo F., Chen K., O'Sullivan G.C., Kiely B., Collins J.K., Shanahan F., and Quigley E.M. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 128 (2005) 541-551
65. O'Mahony S.M., Marchesi J.R., Scully P., Codling C., Ceolho A.M., Quigley E.M., Cryan J.F., and Dinan T.G. Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses. Biol. Psychiatry 65 (2008) 263-267
66. Ostman S., Rask C., Wold A.E., Hultkrantz S., and Telemo E. Impaired regulatory T cell function in germ-free mice. Eur. J. Immunol. 36 (2006) 2336-2346
67. Owen C., Rees A.M., and Parker G. The role of fatty acids in the development and treatment of mood disorders. Curr. Opin. Psychiatry 21 (2008) 19-24
68. Palmer C., Bik E.M., Digiulio D.B., Relman D.A., and Brown P.O. Development of the human infant intestinal microbiota. PLoS Biol. 5 (2007) e177
69. Pessi T., Sutas Y., Hurme M., and Isolauri E. Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin. Exp. Allergy 30 (2000) 1804-1808
70. Quan N., and Banks W.A. Brain-immune communication pathways. Brain Behav. Immun. 21 (2007) 727-735
71. Rolls A., Shechter R., London A., Ziv Y., Ronen A., Levy R., and Schwartz M. Toll-like receptors modulate adult hippocampal neurogenesis. Nat. Cell Biol. 9 (2007) 1081-1088
72. Rosengren A., Hawken S., Ounpuu S., Sliwa K., Zubaid M., Almahmeed W.A., Blackett K.N., Sitthi-amorn C., Sato H., and Yusuf P.S. Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): case control study. Lancet 364 (2004) 953-962
73. Rousseaux C., Thuru X., Gelot A., et al. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat. Med. 13 1 (2007) 35-37
74. Schicho R., Krueger D., Zeller F., Von Weyhern C.W., Frieling T., Kimura H., Ishii I., De Giorgio R., Campi B., and Schemann M. Hydrogen sulfide is a novel prosecretory neuromodulator in the Guinea-pig and human colon. Gastroenterology 131 (2006) 1542-1552
75. Schiltz J.C., and Sawchenko P.E. Signaling the brain in systemic inflammation: the role of perivascular cells. Front. Biosci. 8 (2003) s1321-s1329
76. Schroeder F.A., Lin C.L., Crusio W.E., and Akbarian S. Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse. Biol. Psychiatry 62 (2007) 55-64
77. Strauss E., and da Costa M.F. The importance of bacterial infections as precipating factors of chronic hepatic encephalopathy in cirrhosis. Hepatogastroenterology 45 (1998) 900-904
78. Sudo N., Chida Y., Aiba Y., Sonoda J., Oyama N., Yu X.N., Kubo C., and Koga Y. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J. Physiol. 558 (2004) 263-275
79. Sudo N. Stress and gut microbiota: does postnatal microbial colonization program the hypothalamic-pituitary-adrenal system for stress response?. Int. Congr. Ser. 1287 (2006) 350-354
80. Talham G.L., Jiang H.Q., Bos N.A., and Cebra J.J. Segmented filamentous bacteria are potent stimuli of a physiologically normal state of the murine gut mucosal immune system. Infect. Immun. 67 (1999) 1992-2000
81. Tanida M., Yamano T., Maeda K., Okumura N., Fukushima Y., and Nagai K. Effects of intraduodenal injection of Lactobacillus johnsonii La1 on renal sympathetic nerve activity and blood pressure in urethane-anesthetized rats. Neurosci. Lett. 389 (2005) 109-114
82. Taylor V., Macdonald K., McKinnon M.C., Joffe R.T., and MacQueen G.M. Increased rates of obesity in first-presentation adults with mood disorders over the course of four-year follow-up. J. Affect. Disord. 109 (2008) 127-131
83. Trayhurn P., and Wood I.S. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br. J. Nutr. 92 (2004) 347-355
84. Tsankova N., Renthal W., Kumar A., and Nestler E.J. Epigenetic regulation in psychiatric disorders. Nat. Rev. Neurosci. 8 (2007) 355-367
85. Tsankova N.M., Berton O., Renthal W., Kumar A., Neve R.L., and Nestler E.J. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat. Neurosci. 9 (2006) 519-525
86. Turnbaugh P.J., Ley R.E., Hamady M., Fraser-Liggett C.M., Knight R., and Gordon J.I. The human microbiome project. Nature 449 (2007) 804-810
87. Turnbaugh P.J., Ley R.E., Mahowald M.A., Magrini V., Mardis E.R., and Gordon J.I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444 (2006) 1027-1031
88. Turrin N.P., and Rivest S. Unraveling the molecular details involved in the intimate link between the immune and neuroendocrine systems. Exp. Biol. Med. (Maywood) 229 (2004) 996-1006
89. Umesaki Y., Okada Y., Matsumoto S., Imaoka A., and Setoyama H. Segmented filamentous bacteria are indigenous intestinal bacteria that activate intraepithelial lymphocytes and induce MHC class II molecules and fucosyl asialo GM1 glycolipids on the small intestinal epithelial cells in the ex-germ-free mouse. Microbiol. Immunol. 39 (1995) 555-562
90. Umesaki Y., Setoyama H., Matsumoto S., Imaoka A., and Itoh K. Differential roles of segmented filamentous bacteria and clostridia in development of the intestinal immune system. Infect. Immun. 67 (1999) 3504-3511
91. Ustun T.B., Ayuso-Mateos J.L., Chatterji S., Mathers C., and Murray C.J. Global burden of depressive disorders in the year 2000. Br. J. Psychiatry 184 (2004) 386-392
92. Van Lieshout, R.J., Bienenstock, J., MacQueen, G.M., 2008. A review of candidate pathways underlying the association between asthma and major depressive disorder. Psychosom. Med. PSY.0b013e3181907012.
93. Wang R. Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter?. FASEB J. 16 (2002) 1792-1798
94. Wikoff W.R., Anfora A.T., Liu J., Schultz P.G., Lesley S.A., Peters E.C., and Siuzdak G. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc. Natl. Acad. Sci. USA 106 (2009) 3698-3703
95. Wong D., Dorovini-Zis K., and Vincent S.R. Cytokines, nitric oxide, and cGMP modulate the permeability of an in vitro model of the human blood-brain barrier. Exp. Neurol. 190 (2004) 446-455
96. WHO, 2001. The world health report 2001: mental health: new understanding, new hope. World Health Organization.